Hybrid closed-loop therapy beneficial for children with type 1 diabetes
A mobile app could save lives in India
14 October 2021Study discovers unique brain signature of intimate partner aggression
14 October 2021Hybrid closed-loop therapy beneficial for children with type 1 diabetes
(HealthDay)—For children and adolescents with type 1 diabetes, hybrid closed-loop (HCL) therapy improves glycemic control and quality of life, according to a study published online Oct. 11 in JAMA Pediatrics.
